Clinical Trial Update: Assessment of Health-related Quality of Life After Switching COPD Patients From a Dry Powder Inhaler to a Soft Mist Inhaler Remaining on the Same Inhalative Drug

View source ↗

Summary

A Boehringer Ingelheim study evaluating health-related quality of life after switching COPD patients from a dry powder inhaler to a soft mist inhaler while rema…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Spiriva (tiotropium)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Status: TERMINATED | Results posted: 2024-07-08